Skip to main content

Palvella Therapeutics, Inc.

PVLA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001583648

In the last 90 days, Palvella Therapeutics, Inc. insiders filed 0 open-market purchases and 5 sales; 196 institutions reported holding it in 13F filings for Q2 2026, worth $2.15B in total; no superinvestor holds it.

13F holders, Q3 2025

Institutional positions in Palvella Therapeutics, Inc. as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
100
+33 vs. Q2 2025
Shares held
8.53M
+2.62M (+44.3%) vs. Q2 2025
Total value
$534.5M
+$401.3M (+301.2%) vs. Q2 2025
New holders
42
24 more added
Sold out
9
20 more reduced

Compare with Q2 2025: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting PVLA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2025: 100 institutions
Q1 2021: 0 institutionsQ2 2021: 0 institutionsQ3 2021: 0 institutionsQ4 2021: 0 institutionsQ1 2022: 0 institutionsQ2 2022: 0 institutionsQ3 2022: 0 institutionsQ4 2022: 0 institutionsQ1 2023: 0 institutionsQ2 2023: 0 institutionsQ3 2023: 0 institutionsQ4 2023: 0 institutionsQ1 2024: 0 institutionsQ2 2024: 20 institutionsQ3 2024: 25 institutionsQ4 2024: 33 institutionsQ1 2025: 41 institutionsQ2 2025: 67 institutionsQ3 2025: 100 institutionsQ4 2025: 140 institutionsQ1 2026: 180 institutionsQ2 2026: 196 institutions
Value heldQ3 2025: $534.5M
Q1 2021: $0Q2 2021: $0Q3 2021: $0Q4 2021: $0Q1 2022: $0Q2 2022: $0Q3 2022: $0Q4 2022: $0Q1 2023: $0Q2 2023: $0Q3 2023: $0Q4 2023: $0Q1 2024: $0Q2 2024: $3.57MQ3 2024: $10.1MQ4 2024: $48.4MQ1 2025: $143.4MQ2 2025: $133.2MQ3 2025: $534.5MQ4 2025: $1.02BQ1 2026: $1.64BQ2 2026: $2.15B
Institutions holding PVLA and their total value by quarter
QuarterHoldersValue
Q2 2026196$2.15B
Q1 2026180$1.64B
Q4 2025140$1.02B
Q3 2025100$534.5M
Q2 202567$133.2M
Q1 202541$143.4M
Q4 202433$48.4M
Q3 202425$10.1M
Q2 202420$3.57M
Q1 20240$0
Q4 20230$0
Q3 20230$0
Q2 20230$0
Q1 20230$0
Q4 20220$0
Q3 20220$0
Q2 20220$0
Q1 20220$0
Q4 20210$0
Q3 20210$0
Q2 20210$0
Q1 20210$0

Institutions, Q3 2025

Shares, value and share of portfolio for each institution holding Palvella Therapeutics, Inc.; share changes are against Q2 2025.

Institutions holding PVLA in Q3 2025
InstitutionSharesValue% of portfolioChange in sharesAction
Adams Street Partners LLC0$00.00%−298,986−100.0%Sold out
Marshall Wace, LLP0$00.00%−49,077−100.0%Sold out
UBS Oconnor LLC0$00.00%−43,994−100.0%Sold out
DAFNA Capital Management LLC0$00.00%−43,348−100.0%Sold out
Strid Group, LLC0$00.00%−18,166−100.0%Sold out
XTX Topco Ltd0$00.00%−17,701−100.0%Sold out
SBI Securities Co., Ltd.0$00.00%−12−100.0%Sold out
Twin Peaks Wealth Advisors, LLC0$00.00%−1−100.0%Sold out
Acadian Asset Management LLC0$00.00%−1−100.0%Sold out